申请人:MERCK SHARP & DOHME CORP.
公开号:EP3536319A1
公开(公告)日:2019-09-11
Disclosed are the ERK inhibitors of formula (1):
and the pharmaceutically acceptable salts thereof, wherein: A is a five membered monocyclic heteroaryl ring; and B is a monocyclic heterocycloalkyl ring, or a monocyclic heterocycloalkenyl ring, or a bridged monocyclic heterocycloalkyl ring, or a fused (monocyclic heterocycloalkyl ring)cyclopropyl ring. Also disclosed are methods of treating cancer using the compounds of formula (1).
所公开的是式 (1) 的 ERK 抑制剂:
及其药学上可接受的盐类,其中A 是五元单环杂芳基环;B 是单环杂环烷基环、或单环杂环烯基环、或桥接单环杂环烷基环、或融合(单环杂环烷基环)环丙基环。还公开了使用式(1)化合物治疗癌症的方法。